Analyst Upgrades: Amazon.com, Inc., MBIA Inc., and Pfizer Inc.

Analysts upwardly revised their ratings on Amazon.com, Inc. (AMZN), MBIA Inc. (MBI), and Pfizer Inc. (PFE)

Nov 3, 2015 at 9:07 AM
facebook X logo linkedin


Analysts are weighing in on Internet retailer Amazon.com, Inc. (NASDAQ:AMZN), insurance issue MBIA Inc. (NYSE:MBI), and pharmaceutical blue chip Pfizer Inc. (NYSE:PFE). Here's a quick roundup of today's bullish brokerage notes on AMZN, MBI, and PFE.

  • As of last night's close at $628.35, AMZN shares have more than doubled year-to-date, boosted by a recent earnings beat. Despite receiving a price-target lift to $800 from $725 at Deutsche Bank overnight, though, the stock is pointed 0.3% lower pre-market. In recent months, option traders have been gambling on losses for Amazon.com, Inc., per data from the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). Specifically, the equity's 50-day put/call volume ratio of 1.07 ranks in the bearish 92nd percentile of its annual range. In other news, AMZN will be opening its first physical bookstore today in Seattle, called Amazon Books, and announced an expanded family-leave policy (subscription required) to attract and retain talent.
  • MKM Partners boosted its assessment of MBI to "buy" from "neutral," ahead of the company's third-quarter earnings report tomorrow night. The bullish note has the shares up 2.7% ahead of the bell, as they try to claw their way back from a nearly 19% year-to-date deficit, as of Monday's close at $7.74. Option players have been rolling the dice on post-earnings upside for MBIA Inc., buying to open more than 18 calls for every put during the past two weeks. The corresponding ISE/CBOE/PHLX call/put volume ratio of 18.13 registers a mere 6 percentage points from a 12-month peak.
  • Amid reports that GlaxoSmithKline plc (ADR) (NYSE:GSK) rebuffed a PFE buyout attempt prior to the latter's talks with Allergan PLC (NYSE:AGN), shares of the blue chip saw their price target raised to $41 from $40 at Credit Suisse. As such, Pfizer Inc. is headed slightly higher in electronic trading, hoping to build on its 12.6% year-to-date advance, as of yesterday's close at $35.06. The options crowd certainly is expecting more upside from the drugmaker. At the ISE, CBOE, and PHLX, PFE has racked up a 10-day call/put volume ratio of 5.36 -- which ranks in the 84th percentile of its annual range. In other words, traders have been buying to open calls over puts at an accelerated clip of late.
Get the skinny on all the biggest stories of the morning… Sign up now to get Schaeffer's Midday Market Check delivered straight to your inbox!
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI